In this article, we will look at the 10 Best Strong Buy Stocks to Invest In Under $20.
On March 23, Dan Niles, founder and portfolio manager at Niles Investment Management, appeared on CNBC’s ‘Squawk on the Street’ to talk about market themes and the war in Iran. President Trump recently announced productive talks with Iran on the Iran war, with positive steps when it comes to negotiations and the potential end of the conflict. Niles was of the view that in these circumstances, one has to look at what the risk-adjusted returns are looking like. He has been negative about how this will play out, because it takes one person to start a war but two to end it.
READ ALSO: 12 Best Long Term Stocks to Invest In According to Billionaires AND 11 Best Ethical Companies to Invest In Now According to Reddit.
On Friday, he stated that the market overall is oversold in the sense that it is not stocks that got him really interested; you look at bonds, and since the end of February, you look at the two-year, it has moved up 50 basis points, and you were pricing in rate hikes and not cuts for the rest of the year. In addition to that, gold was getting absolutely killed. Therefore, he said that in late February it was overbought, and on Friday, it was oversold.
With these broader market trends in view, let’s look at the best strong buy stocks to invest in under $20.
Our Methodology
We used the Finviz stock screener to compile a list of the best stocks under $20 with consensus Strong Buy ratings and selected the top 10 most popular among elite hedge funds as of Q3 2025. We sourced the hedge fund data from Insider Monkey’s database. The stocks are ranked in ascending order of hedge fund sentiment.
Note: All data was recorded on March 23.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10 Best Strong Buy Stocks to Invest In Under $20
10. ImmunityBio Inc. (NASDAQ:IBRX)
ImmunityBio Inc. (NASDAQ:IBRX) is one of the best strong buy stocks to invest in under $20. ImmunityBio Inc. (NASDAQ:IBRX) announced on March 20 that the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region of the People’s Republic of China granted regulatory approval for ANKTIVA®. Management stated that the approval establishes ANKTIVA’s initial presence in Asia, while highlighting ImmunityBio Inc.’s (NASDAQ:IBRX) strategy for the expansion of global access through reliance-based regulatory pathways.
The company further reported that ANKTIVA gained approval in combination with Bacillus Calmette-Guérin in Macau, for adult patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ ± papillary tumors, which is consistent with its approved use in the United States. It also stated that the authorization was granted after a review considering previous regulatory decisions by the U.S. Food and Drug Administration and the European Medicines Agency, in accordance with applicable local requirements.
Patrick Soon-Shiong, M.D., Founder, Executive Chairman and Global Chief Scientific and Medical Officer of ImmunityBio Inc. (NASDAQ:IBRX), stated that the approval in Macau highlights the “strength of the clinical and regulatory foundation supporting ANKTIVA in BCG-unresponsive NMIBC CIS, with or without papillary tumors”.
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat cancer and infectious diseases. Its immunotherapy platform activates the adaptive and innate immune systems to create long-term immunological memory.
9. SailPoint, Inc. (NASDAQ:SAIL)
SailPoint, Inc. (NASDAQ:SAIL) is one of the best strong buy stocks to invest in under $20. On March 19, Scotiabank cut the price target on SailPoint, Inc. (NASDAQ:SAIL) to $16 from $24 and reiterated an Outperform rating on the shares. The firm told investors that it likes the company’s position as the number 1 player competitively in governance. It added that with expectations reset to a level that looks “conservative,” the firm believes the current risk/reward profile skews up.
SailPoint, Inc. (NASDAQ:SAIL) also received a rating update from RBC Capital on March 19. The firm cut the price target on the stock to $19 from $23, but reaffirmed an Outperform rating on the shares. It told investors in a research note that the company posted a solid end to the year with annualized recurring revenue growth of 28%. It added that although the beat margin was smaller, RBC Capital remains encouraged by SailPoint, Inc.’s (NASDAQ:SAIL) medium-term business trends.
SailPoint, Inc. (NASDAQ:SAIL) provides an elaborate identity security platform for the enterprise, with its solutions allowing organizations to control, establish, and automate policies that allow them to attain regulatory compliance and define and maintain a robust security posture.
